Top Markets
Coin of the day
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SION
Rank in Stocks #16558
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is... Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Share Price
$6.36
Last synced: 2026-09-01
Market Cap
$287.06M
Change (1 day)
5.44%
Change (1 year)
-74.96%
Country
US
Trade Sionna Therapeutics, Inc. (SION)

Category

EPS for Sionna Therapeutics, Inc. (SION)
EPS as of 2026 TTM: 0
According to Sionna Therapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Sionna Therapeutics, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH